Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Endocrine Disruptors: Epidemiological Approaches, RFA OH-01-001

---
identifier: "/us/fr/00-30515"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Endocrine Disruptors: Epidemiological Approaches, RFA OH-01-001"
title_number: 0
title_name: "Federal Register"
section_number: "00-30515"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Endocrine Disruptors: Epidemiological Approaches, RFA OH-01-001"
positive_law: false
currency: "2000-11-30"
last_updated: "2000-11-30"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "00-30515"
document_type: "notice"
publication_date: "2000-11-30"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "65 FR 71323"
fr_volume: 65
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Endocrine Disruptors: Epidemiological Approaches, RFA OH-01-001

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting.

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Endocrine Disruptors: Epidemiological Approaches, RFA OH-01-001, meeting.

*Times and Dates:* 8 a.m.-8:30 a.m., February 1, 2001 (Open), 8:30 a.m.-5 p.m., February 1, 2001 (Closed), 8 a.m.-5 p.m., February 2, 2001 (Closed).

*Place:* Embassy Suites Hotel, 315 Julia Street, New Orleans, Louisiana 70130.

*Status:* Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Associate Director for Management and Operations, CDC, pursuant to Public Law 92-463.

*Matter to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to Program Announcement RFA OH-01-001.

*Contact Person for more Information:* Pervis C. Major, Ph.D., Scientific Review Administrator, National Institute for Occupational Safety and Health, 1095 Willowdale Rd., Morgantown, WV 26505. Phone 304/285-5979, e-mail [email protected].

The Director, Management Analysis and Services office has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: November 21, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention CDC.